Recruiting
Phase 3

Laparoscopic Gastric Bypass & Omentectomy

Sponsor:

Legacy Health System

Code:

NCT00552942

Conditions

Diabetes

Interleukins

Cytokines

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

laparoscopic gastric bypass plus omentectomy

Study Details

Brief summary:

To see if removing the omentum in addition to a gastric bypass improves diabetes is better than just a gastric bypass.

Conditions

Diabetes

Interleukins

Cytokines

Study ID

NCT00552942

Start date

Jul, 2006

Status verified date

Nov, 2007

Completion date

Jul, 2008

Anticipated

Eligibility Criteria

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Inclusion Criteria:

  • undergoing laparoscopic gastric bypass, >18 yo, understands english

Exclusion Criteria:

  • previous lower pelvic surgery, self-pay patients, previous weight loss surgery,

Study Design

Enrollment

40 participants

Anticipated

Allocation

Randomized

Intervention Model

Parallel Assignment

Primary purpose

Treatment

Interventions and Outcome Measures

Arms

experimental: 1

surgery plus omentectomy

no intervention: 2

standard gastric bypass

Interventions

laparoscopic gastric bypass plus omentectomy

Primary outcome measure

  • diabetic indices [ Time Frame: 6 months ]

Central Contacts and Locations

Central contacts

Dennis Hong, MD, MS.c, FRCSC

503-227-5050dennishong70@gmail.com

Locations

Oregon Weight Loss Surgery LLC

Recruiting

Portland, Oregon, United States, 97210

Contacts

Dennis Hong, MD, MS.,c, FRCSC

503-227-5050dennishong70@gmail.com

More Information

Sponsor

Legacy Health System

Last update posted

Nov 2, 2007

Last verified

Nov, 2007

Keywords

  • obesity
  • diabetes
  • cytokines

Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-10. This information was provided to ClinicalTrials.gov by Legacy Health System on 2007-11-02.